MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
Authors
Keywords
-
Journal
Diagnostic Pathology
Volume 13, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-03
DOI
10.1186/s13000-018-0763-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
- (2017) Sang Joon Park et al. MEDICINE
- Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review)
- (2016) Patrick Reichl et al. ONCOLOGY REPORTS
- Genetic alterations in hepatocellular carcinoma: An update
- (2016) Zhao-Shan Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy
- (2015) A. M. Eiden et al. CLINICAL CANCER RESEARCH
- Update on Biomarkers of Hepatocellular Carcinoma
- (2015) Roongruedee Chaiteerakij et al. Clinical Gastroenterology and Hepatology
- Evaluation and Management of Hepatocellular Carcinoma
- (2015) Laura M. Kulik et al. Clinics in Liver Disease
- RETRACTED ARTICLE: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues
- (2015) Hossein Ajdarkosh et al. Diagnostic Pathology
- PI3K and AKT: Unfaithful Partners in Cancer
- (2015) Seraina Faes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The PI3K/AKT/mTOR interactive pathway
- (2015) Tulin Ersahin et al. Molecular BioSystems
- Hepatocellular carcinoma epidemiology
- (2014) Cristina Bosetti et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Targeting PI3K/Akt/mTOR Signaling in Cancer
- (2014) Camillo Porta et al. Frontiers in Oncology
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
- (2012) A. G. Singal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
- (2011) Naoshi Nishida et al. CURRENT GENOMICS
- Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
- (2011) Qian Zhou et al. Future Oncology
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
- (2009) S. Mabuchi et al. CLINICAL CANCER RESEARCH
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
- (2008) Timothy A Yap et al. CURRENT OPINION IN PHARMACOLOGY
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started